/
INFU
$9.88-$0.17 (-1.69%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$202.8M
20M shares
52-week range
$5.38 – $11.04
80% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
XASE
CS
Borrow rate
0.30%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-10.91
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $67.1M | $81.1M | $97.4M | $102.4M | $109.9M | $125.8M | $134.9M | $143.4M |
| Cost of revenue | $28.1M | $34.2M | $38.6M | $43.8M | $49.4M | $62.7M | $64.5M | $63.1M |
| Gross profit | $39.0M | $46.9M | $58.8M | $58.5M | $60.6M | $63.1M | $70.4M | $80.3M |
| Gross margin | 58.1% | 57.8% | 60.3% | 57.2% | 55.1% | 50.2% | 52.2% | 56.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $415.0K | $3.5M | $8.8M | $2.8M | $1.7M | $4.1M | $6.9M | $11.9M |
| EBITDA | $11.7M | $15.8M | $22.8M | $17.3M | $14.9M | $16.5M | $20.0M | $25.2M |
| Net income | −$1.1M | $1.4M | $17.3M | $1.4M | $18.0K | $872.0K | $2.3M | $6.6M |
| Net margin | -1.6% | 1.7% | 17.8% | 1.4% | 0.0% | 0.7% | 1.7% | 4.6% |
| EPS (diluted) | -0.05 | 0.07 | 0.80 | 0.06 | 0.00 | 0.04 | 0.11 | 0.31 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $145M | $0.42 | $0.42–$0.43 | 3 |
| 2027 | $156M | $0.55 | $0.54–$0.55 | 3 |
| 2028 | $165M | $0.00 | $0.00–$0.00 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$8.00
Price
$9.88
Implied downside
-19%
Peer comparison
InfuSystem Holdings, Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
www.infusystem.com- Employees
- 473
- IPO / List date
- Dec 22, 1992
- HQ
- ROCHESTER HILLS, MI
Held by traders on TradeandTell
No one on the platform currently holds INFU.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 566,809 | $5.2M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded INFU yet.
